Lantern Pharma Inc (LTRN)
5.765
-0.38
(-6.11%)
USD |
NASDAQ |
May 20, 16:00
5.765
0.00 (0.00%)
After-Hours: 20:00
Lantern Pharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Eyenovia Inc | 8.205 |
Cassava Sciences Inc | -- |
Alpine Immune Sciences Inc | 0.00 |
Clearside Biomedical Inc | 0.00 |
Poseida Therapeutics Inc | 0.6938 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 39.73M |
Total Liabilities (Quarterly) | 3.969M |
Shareholders Equity (Quarterly) | 35.77M |